Table 1. Baseline characteristics, univariate and multivariate analysis of factors associated with loss to follow-up before becoming eligible for antiretroviral therapy of 282 children in Anantapur, India.
| N (%) | SHR (95% CI) | aSHR (95% CI) | |
| Age (years) | |||
| 0-1 | 27 (9.57) | 0.23 (0.03-1.72) | 0.54 (0.04-7.97) |
| 2-4 | 102 (36.17) | 0.80 (0.39-1.63) | 1.66 (0.46-6.06) |
| 5-9 | 117 (41.49) | 1 (Reference) | 1 (Reference) |
| 10-14 | 36 (12.77) | 0.50 (0.15-1.67) | 0.12* (0.03-0.55) |
| Gender | |||
| Female | 148 (52.48) | 1.01 (0.52-1.94) | 1.15 (0.56-2.39) |
| Male | 134 (47.52) | 1 (Reference) | 1 (Reference) |
| Community | |||
| OC | 58 (20.57) | 1.16 (0.48-2.82) | 0.96 (0.35-2.65) |
| BC | 145 (51.42) | 1 (Reference) | 1 (Reference) |
| SC | 63 (22.34) | 1.69 (0.75-3.81) | 1.31 (0.50-3.43) |
| ST | 16 (5.67) | 2.37 (0.85-6.56) | 2.36 (0.77-7.18) |
| Living near a town | |||
| No | 178 (63.12) | 1 (Reference) | 1 (Reference) |
| Yes | 104 (36.88) | 0.94 (0.48-1.84) | 0.89 (0.40-1.98) |
| Time to the clinics | |||
| ≤30 min | 79 (28.01) | 1 (Reference) | 1 (Reference) |
| >30 min | 203 (71.99) | 2.00 (0.82-4.85) | 2.09 (0.73-5.96) |
| Year of enrolment | |||
| 2007 | 44 (15.6) | 1 (Reference) | 1 (Reference) |
| 2008 | 57 (20.21) | 0.78 (0.20-3.06) | 0.58 (0.14-2.44) |
| 2009 | 63 (22.34) | 1.64 (0.52-5.18) | 1.30 (0.36-4.69) |
| 2010 | 55 (19.5) | 2.03 (0.65-6.28) | 2.05 (0.62-6.76) |
| 2011 | 32 (11.35) | 2.05 (0.58-7.31) | 2.02 (0.51-8.00) |
| 2012 | 31 (10.99) | 3.07 (0.84-11.16) | 3.48 (0.97-12.51) |
| Status of parents | |||
| Alive, rented house | 81 (28.72) | 1 (Reference) | 1 (Reference) |
| Alive, owned house | 68 (24.11) | 0.84 (0.35-1.99) | 0.64 (0.24-1.69) |
| Father died | 71 (25.18) | 0.56 (0.22-1.39) | 0.26* (0.09-0.75) |
| Mother died | 32 (11.35) | 0.74 (0.25-2.26) | 0.51 (0.15-1.79) |
| Both died | 30 (10.64) | 0.59 (0.18-1.96) | 0.47 (0.14-1.57) |
| 12-month AIDS risk | |||
| <3% | 67 (23.76) | 3.02* (1.09-8.39) | 10.77* (1.93-60.07) |
| 3-3.4% | 117 (41.49) | 1.59 (0.56-4.50) | 1.34 (0.33-5.48) |
| 3.5-3.9% | 27 (9.57) | 2.36 (0.60-9.20) | 1.65 (0.33-8.28) |
| ≥4% | 71 (25.18) | 1 (Reference) | 1 (Reference) |
*p-value <0.05.
ART antiretroviral therapy; aSHR adjusted sub-distribution hazard ratio; BC backward castes; CI confidence interval; N number; OC other castes; SHR sub-distribution hazard ratio; SC scheduled castes; ST scheduled tribes.